chr16-4777828-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144605.5(SEPTIN12):c.1046G>A(p.Gly349Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000467 in 1,583,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144605.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN12 | NM_144605.5 | c.1046G>A | p.Gly349Glu | missense_variant | 10/10 | ENST00000268231.13 | NP_653206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEPTIN12 | ENST00000268231.13 | c.1046G>A | p.Gly349Glu | missense_variant | 10/10 | 1 | NM_144605.5 | ENSP00000268231.8 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 23AN: 200516Hom.: 0 AF XY: 0.000111 AC XY: 12AN XY: 108372
GnomAD4 exome AF: 0.0000412 AC: 59AN: 1431622Hom.: 0 Cov.: 32 AF XY: 0.0000423 AC XY: 30AN XY: 709414
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.1046G>A (p.G349E) alteration is located in exon 10 (coding exon 9) of the SEPT12 gene. This alteration results from a G to A substitution at nucleotide position 1046, causing the glycine (G) at amino acid position 349 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at